Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 447

Similar articles for PubMed (Select 19301940)

1.

Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study.

Snyman JR, Schoeman HS, Grobusch MP, Henning M, Rabie W, Hira M, Parshotam K, Mithal Y, Singh S, Ramdas Z.

Clin Drug Investig. 2009;29(4):265-74. doi: 10.2165/00044011-200929040-00005.

PMID:
19301940
2.
3.

Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.

Adam D, Glaser-Caldow E, Wachter J, Brueckner OJ, Hein J, Kroemer B, Hirsch J.

Clin Ther. 2001 Apr;23(4):585-95.

PMID:
11354392
4.
5.
7.

Comparison of once- and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infections.

Allin D, James I, Zachariah J, Carr W, Cullen S, Middleton A, Newson P, Lytle T, Coles S.

Clin Ther. 2001 Dec;23(12):1958-68.

PMID:
11813931
8.
9.
12.
14.
15.
16.

Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.

Gotfried MH.

Expert Rev Anti Infect Ther. 2003 Jun;1(1):9-20. Review.

PMID:
15482099
17.

Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study.

Portier H, Filipecki J, Weber P, Goldfarb G, Lethuaire D, Chauvin JP.

J Antimicrob Chemother. 2002 Feb;49(2):337-44.

18.

Clarithromycin extended-release in community-acquired respiratory tract infections.

Williams KN, Bishai WR.

Expert Opin Pharmacother. 2005 Dec;6(16):2867-76. Review.

PMID:
16318437
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk